PhRMA Foundation awards grants to fight health disparities with digital health tools

The PhRMA Foundation (PhF) awarded $500,000 grants to David G. Armstrong, DPM, MD, PhD, of the University of Southern California and Nino Isakadze, MD, MHS, of Johns Hopkins University to conduct research using digital health technologies (DHTs) to improve health equity and health outcomes for patients.

Improved kidney transplant success from deceased donors with dialysis history

Researchers compare the outcomes of kidney transplants, in which the kidneys were from deceased donors who had or had not undergone dialysis.

May 31, 2024

Filament Health Announces Warrant Exercise and Note Conversion by Negev Capital and Concurrent Private Placement of Common Shares to Benjamin Lightburn, Chief Executive Officer | Psychedelic Invest

VANCOUVER, BC, June 3, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, today

June 3, 2024

Federal Bill To Decriminalize All Illicit Drugs Set For Reintroduction

A bill to federally decriminalize possession of all illicit drugs and promote mass expungements is set to be reintroduced in Congress. Reps. Bonnie Watson Coleman (D-NJ)

June 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.